moderna stock
Intismeran, developed with Merck, met both objectives of the study in 1,137 patients. It could be available as early as 2027
Peak volume
2K+
First seen
2026-08-19
Last seen
2026-08-19
Days trending
1 / 1
Countries
24
Intismeran, developed with Merck, met both objectives of the study in 1,137 patients. It could be available as early as 2027